Neurology/CNS

This segment of NovaMedica’s portfolio currently includes the following products:


Seroquel® – a modern the 2nd generation antipsychotic for:

- Contradictory long-term therapy in patients with a chronic course of schizophrenia;

- Treatment of patients with newly diagnosed schizophrenia;

- Correction of negative symptoms and cognitive deficit in patients with schizophrenia;

- Therapy of schizophrenia patients with therapeutic resistance to traditional neuroleptics.

Seroquel® Prolong – is an antipsychotic (neuroleptic) for the treatment of:

- Schizophrenia, including relapse prevention in stable patients;

- Bipolar disorders, including: moderate and severe manic episodes in the structure of bipolar disorder, severe episodes of depression in the structure of bipolar disorder, prevention of relapse of bipolar disorders in patients with prior effective quetiapine therapy of manic or depressive episodes in the structure of bipolar disorder.

All products passed Clinical Trials and registered in Russia.

PRODUCTS HAVE CONTRAINDICATIONS. PLEASE CONSULT A SPECIALIST BEFORE USE

Shareholders

Read more

Pipeline

Read more

Media Center

Read more